Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-039745
Filing Date
2021-10-08
Accepted
2021-10-08 18:00:18
Documents
2
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3856
2 EX-24 DOCUMENT attachment1.htm EX-24 4817
  Complete submission text file 0000899243-21-039745.txt   10274
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM CHESHIRE X0 WA14 2DT
Business Address
GRAINGER DAVID J (Reporting) CIK: 0001887115 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40445 | Film No.: 211316258